Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2014 1
2015 1
2016 1
2017 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Statin-Based Palliative Therapy for Hepatocellular Carcinoma.
Shao JY, Lee FP, Chang CL, Wu SY. Shao JY, et al. Medicine (Baltimore). 2015 Oct;94(42):e1801. doi: 10.1097/MD.0000000000001801. Medicine (Baltimore). 2015. PMID: 26496314 Free PMC article.
Differences in HBV- and non-HBV-related HCC were solely due to statin use. Statin use alone reduced HCC-specific deaths by 36% in non-HBV-related HCC in stage I and 50% in HBV-related HCC in stages II and III. With a relatively substantial reduction in …
Differences in HBV- and non-HBV-related HCC were solely due to statin use. Statin use alone reduced HCC-specific deaths by 36% …
Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT, Liu RB, Liang YY, Hasan AME, Wang HY, Shao Q, Zhang ZC, Wang J, He CY, Wang F, Shao JY. Zhu HT, et al. Among authors: shao jy. Liver Int. 2017 Jun;37(6):888-896. doi: 10.1111/liv.13356. Epub 2017 Feb 3. Liver Int. 2017. PMID: 28061012
BACKGROUND & AIMS: The discovery of effective and reliable biomarkers to detect hepatitis B virus (HBV)-positive hepatocellular carcinoma (HCC) at an early stage may improve the survival of HCC. The aim of this study was to establish serum microRNA (miRNA) profi …
BACKGROUND & AIMS: The discovery of effective and reliable biomarkers to detect hepatitis B virus (HBV)-positive hepatocellular carcinom …
Plasma SGIP1 methylation in diagnosis and prognosis prediction in hepatocellular carcinoma.
Xie GF, Xu YX, Xu F, Sun LY, Ye ZL, Ma JJ, Wang HY, Shao JY. Xie GF, et al. Among authors: shao jy. Neoplasma. 2020 Oct 30:200623N657. doi: 10.4149/neo_2020_200623N657. Online ahead of print. Neoplasma. 2020. PMID: 33118832
Aberrant methylation of some genes can serve as promising biomarkers in hepatocellular carcinoma (HCC). This study aimed to investigate the diagnostic and prognostic value of plasma SGIP1 methylation in HCC. ...The AUC was 0.728 in distinguishing HCC from LC, …
Aberrant methylation of some genes can serve as promising biomarkers in hepatocellular carcinoma (HCC). This study aimed to investiga …
Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT, Hasan AM, Liu RB, Zhang ZC, Zhang X, Wang J, Wang HY, Wang F, Shao JY. Zhu HT, et al. Among authors: shao jy. Oncotarget. 2016 Jul 19;7(29):45637-45648. doi: 10.18632/oncotarget.10082. Oncotarget. 2016. PMID: 27317768 Free PMC article.
MiR-192-5p and miR-29a-3p were identified and associated with HCC prognosis. HCCs with high concentrations of miR-192-5p and miR-29a-3p had poorer overall survival (OS) and progression-free survival (PFS) than those with low concentrations. ...
MiR-192-5p and miR-29a-3p were identified and associated with HCC prognosis. HCCs with high concentrations of miR-192-5p and miR-29a- …
ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
Jia SW, Fu S, Wang F, Shao Q, Huang HB, Shao JY. Jia SW, et al. Among authors: shao jy. World J Gastroenterol. 2014 Jan 7;20(1):183-92. doi: 10.3748/wjg.v20.i1.183. World J Gastroenterol. 2014. PMID: 24415871 Free PMC article.
RESULTS: ALK gene translocation was not observed in any of the HCC cases included in the present study. ALK gene copy number gain (ALK/CNG) ( 4 copies/cell) was detected in 28 (13.15%) of the 213 HCC patients. ...Multivariate Cox proportional hazards regression anal …
RESULTS: ALK gene translocation was not observed in any of the HCC cases included in the present study. ALK gene copy number gain (AL …
Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia.
Shao JY, Gao HY, Li YH, Zhang Y, Lu YY, Zeng YX. Shao JY, et al. World J Gastroenterol. 2004 Jun 1;10(11):1560-4. doi: 10.3748/wjg.v10.i11.1560. World J Gastroenterol. 2004. PMID: 15162525 Free PMC article.
RESULTS: A novel CD (4 981 bp) was detected in 85% (23/27) and 83%(22/27) of HCC and HNH tumor tissues, respectively, which were significantly higher than that in paired noncancerous liver tissues (57%, 15/27) (P<0.05). ...CONCLUSION: CD-mtDNA mutation plays an importan …
RESULTS: A novel CD (4 981 bp) was detected in 85% (23/27) and 83%(22/27) of HCC and HNH tumor tissues, respectively, which were sign …
Feedback